Nanomaterials and Nanofabrication Labs

PO. Box 2168
Fayetteville, AR 72702
http://www.nn-labs.com
9 Employees

SBIR Award Summary

Total Number of Awards 16
Total Value of Awards $4.15MM
First Award Date 07/09/03
Most Recent Award Date 08/01/10

Key Personnel

Last Name Name Awards Contact
Wang Dr. Yunjun Wang 2 Message
Wang Yunjun Wang 1
Wang Y Andrew Wang 1
Liu Yongcheng Liu 6
Battaglia David Mark Battaglia 2
Mao Hua Mao 2
Chen Dawei Chen 1
Qiao Tiecheng Alex Qiao 1

16 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-009
Budget: 08/01/10 - 07/31/11
PI: Hua Mao

DESCRIPTION (provided by applicant): This SBIR Phase II program aims to develop a novel class of commercial products of near infrared (NIR) nanolabels based on colloidal non-cadmium quantum dots, InAs/InP/ZnSe core/shell/shell dots coated with dendron ligands. NIR emitters are outstanding bio-medical labels because of the close-to-zero backgroun...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/30/09 - 05/15/11

DESCRIPTION (provided by applicant): Nanomaterials and Nanofabrication Laboratories Program Announcement No. PA-08-050 (NN-Labs, LLC) Title: Near Infrared Semiconductor Nanocrystal for Imaging Guided Surgery Principal Investigator: Tiecheng Qiao Summary The incidence of brain metastasis in patients with melanoma ranges from 10% to 40% and is eve...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-009
Budget: 08/01/09 - 07/31/10
PI: Hua Mao

DESCRIPTION (provided by applicant): This SBIR Phase II program aims to develop a novel class of commercial products of near infrared (NIR) nanolabels based on colloidal non-cadmium quantum dots, InAs/InP/ZnSe core/shell/shell dots coated with dendron ligands. NIR emitters are outstanding bio-medical labels because of the close-to-zero backgroun...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): This SBIR Phase II program intends to develop the second generation of semiconductor nanocrystals (q-dots) based bio-medical labels to eliminate the usage of toxic cadmium element, to be physically permeable, and to not possess any self-quenching of the photoluminescence. This will be realized by a new invent...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 01/15/08 - 07/14/08

DESCRIPTION (provided by applicant): This SBIR Phase I project intends to develop a novel nanotechnology for low-cost commercial production of deoxyribonucleoside triphosphates by conjugating all three enzymes with superparamagnetic nanocrystals (Nano-Enzymes). Deoxiribonucleoside triphosphates, with a billion-dollar market, are the precursors f...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): This SBIR proposal intends to develop a nanocrystal biosensor, which is capable of simultaneously detecting and quantifying multiple traumatic brain injury (TBI)-specific biomarkers in relatively small volumes of whole blood (0.1-1 uL). The biosensor design utilizes the well-known size dependent photoluminesc...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): This SBIR Phase II program intends to develop the second generation of semiconductor nanocrystals (q-dots) based bio-medical labels to eliminate the usage of toxic cadmium element, to be physically permeable, and to not possess any self-quenching of the photoluminescence. This will be realized by a new invent...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/30/06 - 08/31/07

DESCRIPTION (provided by applicant): This SBIR Phase II program intends to develop the second generation of semiconductor nanocrystals (q-dots) based bio-medical labels to eliminate the usage of toxic cadmium element, to be physically permeable, and to not possess any self-quenching of the photoluminescence. This will be realized by a new invent...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-25
Budget: 08/01/06 - 07/31/07

DESCRIPTION (provided by applicant): This NIH SBIR project intends to develop three product lines of near infrared (NIR) bio-medical labeling reagents based on semiconductor nanocrystals (NIR NanoLabels), including conventional core/shell nanocrystals, type-II core/shell nanocrystals, and quantum well type-ll nanocrystals. NIR fluorescence label...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-25
Budget: 08/01/06 - 01/31/07

DESCRIPTION (provided by applicant): This SBIR program intends to develop a group of new technologies for the large scale and inexpensive production of bio-labels based on gold nanocrystals (GoldTagsTM). Gold nanocrystals, usually known as colloidal gold, have been widely explored for bio-labeling for many years and are the only type of nanocrys...

Load More